These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34889011)

  • 1. Biosynthesis of Gut-Microbiota-Derived Lantibiotics Reveals a Subgroup of S8 Family Proteases for Class III Leader Removal.
    Zhang Y; Hong Z; Zhou L; Zhang Z; Tang T; Guo E; Zheng J; Wang C; Dai L; Si T; Wang H
    Angew Chem Int Ed Engl; 2022 Feb; 61(6):e202114414. PubMed ID: 34889011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zn-dependent bifunctional proteases are responsible for leader peptide processing of class III lanthipeptides.
    Chen S; Xu B; Chen E; Wang J; Lu J; Donadio S; Ge H; Wang H
    Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2533-2538. PubMed ID: 30679276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refactoring and Heterologous Expression of Class III Lanthipeptide Biosynthetic Gene Clusters Lead to the Discovery of
    Xue D; Shang Z; Older EA; Zhong Z; Pulliam C; Peter K; Nagarkatti M; Nagarkatti P; Li YX; Li J
    ACS Chem Biol; 2023 Mar; 18(3):508-517. PubMed ID: 36926816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous Expression of Mersacidin in
    Viel JH; Jaarsma AH; Kuipers OP
    ACS Synth Biol; 2021 Mar; 10(3):600-608. PubMed ID: 33689311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lantibiotics: promising candidates for future applications in health care.
    Dischinger J; Basi Chipalu S; Bierbaum G
    Int J Med Microbiol; 2014 Jan; 304(1):51-62. PubMed ID: 24210177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of phosphorylated lantibiotics with proimmune activity that regulate the oral microbiome.
    Barbour A; Smith L; Oveisi M; Williams M; Huang RC; Marks C; Fine N; Sun C; Younesi F; Zargaran S; Orugunty R; Horvath TD; Haidacher SJ; Haag AM; Sabharwal A; Hinz B; Glogauer M
    Proc Natl Acad Sci U S A; 2023 May; 120(22):e2219392120. PubMed ID: 37216534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruminococcin C, an anti-clostridial sactipeptide produced by a prominent member of the human microbiota
    Balty C; Guillot A; Fradale L; Brewee C; Boulay M; Kubiak X; Benjdia A; Berteau O
    J Biol Chem; 2019 Oct; 294(40):14512-14525. PubMed ID: 31337708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class I and Class II Lanthipeptides Produced by Bacillus spp.
    Barbosa J; Caetano T; Mendo S
    J Nat Prod; 2015 Nov; 78(11):2850-66. PubMed ID: 26448102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing.
    Völler GH; Krawczyk JM; Pesic A; Krawczyk B; Nachtigall J; Süssmuth RD
    Chembiochem; 2012 May; 13(8):1174-83. PubMed ID: 22556031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics.
    Escano J; Stauffer B; Brennan J; Bullock M; Smith L
    Microbiologyopen; 2014 Dec; 3(6):961-72. PubMed ID: 25400246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of the leader sequence for directing lanthionine formation in lacticin 481.
    Patton GC; Paul M; Cooper LE; Chatterjee C; van der Donk WA
    Biochemistry; 2008 Jul; 47(28):7342-51. PubMed ID: 18570437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic aspects of lanthipeptide leaders.
    Plat A; Kuipers A; Rink R; Moll GN
    Curr Protein Pept Sci; 2013 Mar; 14(2):85-96. PubMed ID: 23441895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteroidetes can be a rich source of novel lanthipeptides: The case study of Pedobacter lusitanus.
    Caetano T; van der Donk W; Mendo S
    Microbiol Res; 2020 May; 235():126441. PubMed ID: 32109689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Putative Novel Class-I Lanthipeptides in Firmicutes: A Combinatorial
    Alkhalili RN; Canbäck B
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational Studies of the Mersacidin Leader Reveal the Function of Its Unique Two-Step Leader Processing Mechanism.
    Viel JH; Kuipers OP
    ACS Synth Biol; 2022 May; 11(5):1949-1957. PubMed ID: 35504017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis and transport of the lantibiotic mutacin 1140 produced by Streptococcus mutans.
    Escano J; Stauffer B; Brennan J; Bullock M; Smith L
    J Bacteriol; 2015 Apr; 197(7):1173-84. PubMed ID: 25605307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the attrition rate of Lanthipeptide discovery for commercial applications.
    Geng M; Smith L
    Expert Opin Drug Discov; 2018 Feb; 13(2):155-167. PubMed ID: 29195488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile Removal of Leader Peptides from Lanthipeptides by Incorporation of a Hydroxy Acid.
    Bindman NA; Bobeica SC; Liu WR; van der Donk WA
    J Am Chem Soc; 2015 Jun; 137(22):6975-8. PubMed ID: 26006047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Screening of Lanthipeptide Analogs via In-Colony Removal of Leader Peptides in Escherichia coli.
    Si T; Tian Q; Min Y; Zhang L; Sweedler JV; van der Donk WA; Zhao H
    J Am Chem Soc; 2018 Sep; 140(38):11884-11888. PubMed ID: 30183279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Application of Lantibiotics and Other Lanthipeptides: Old and New Findings.
    van Staden ADP; van Zyl WF; Trindade M; Dicks LMT; Smith C
    Appl Environ Microbiol; 2021 Jun; 87(14):e0018621. PubMed ID: 33962984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.